CHMP5 and COVID-19: It cannot be excluded that P2Y12 or GPVI may interact with the complex because ADP- or collagen-stimulated platelet reactivity was modulated by spike protein in vitro or in COVID-19 patients with active SARS-CoV-2 infection.